Study guide
14.2 Postoperative Complications & Fluid Therapy
Professional and Linguistic Assessments Board Part 1 PLAB 1
Track your progress as you read
Finished sections get a check mark.
1 Introduction
About the PLAB 1 Exam
2 Chapter 1: Acute Medicine, Resuscitation & Clinical Emergencies
1.1 The ABCDE Approach, Adult Resuscitation & Shock 1.2 Sepsis, Sepsis Six Protocol & Septic Shock 1.3 Anaphylaxis & Acute Airway Emergencies 1.4 Clinical Toxicology & Acute Poisoning 1.5 Major Trauma, Head Injury, Burns & Environmental Emergencies
3 Chapter 2: Cardiovascular Medicine & Vascular Disorders
2.1 Acute Coronary Syndromes (STEMI & NSTEMI/Unstable Angina) 2.2 Heart Failure & Cardiogenic Shock 2.3 Cardiac Arrhythmias & Syncope 2.4 Hypertension, Valvular Heart Disease & Aortic Emergencies 2.5 Infective Endocarditis, Pericardial Disease, Myocarditis & Cardiomyopathies 2.6 Peripheral Arterial Disease, Aortic Aneurysm & Venous Disease
4 Chapter 3: Respiratory Medicine
3.1 Asthma: Diagnostic Criteria, Chronic Stepping & Acute Exacerbations 3.2 COPD: Staging, Long-Term Management & Acute Exacerbations 3.3 Pneumonia & Lower Respiratory Tract Infections 3.4 Venous Thromboembolism, Pleural Disease & Pneumothorax 3.5 Lung Cancer, Interstitial & Suppurative Lung Disease, Sleep Apnoea & Respiratory Failure
5 Chapter 4: Gastroenterology, Hepatobiliary & General Surgery
4.1 Upper Gastrointestinal Bleeding & Dyspepsia 4.2 Lower Gastrointestinal Bleeding, IBD & Colorectal Malignancy 4.3 Acute Abdomen, Bowel Obstruction & Perforation 4.4 Hepatobiliary Disease, Cirrhosis & Acute Pancreatitis 4.5 Functional, Malabsorptive & Infective Bowel Disorders, Anorectal Disease, Hernias & MASLD
6 Chapter 5: Renal Medicine, Urology & Fluid/Electrolyte Balance
5.1 Acute Kidney Injury & KDIGO Staging 5.2 Chronic Kidney Disease & Glomerular Disorders 5.3 Electrolyte Emergencies: Potassium, Sodium & Calcium 5.4 Urology: Urinary Tract Infections, Renal Colic & Urinary Retention 5.5 Urological Cancers, Prostate Disease & Scrotal Emergencies
7 Chapter 6: Endocrinology & Metabolic Medicine
6.1 Diabetes Mellitus: Diagnostic Criteria & Chronic Management 6.2 Diabetic Emergencies: DKA & Hyperosmolar Hyperglycaemic State 6.3 Thyroid Disorders: Hypothyroidism, Thyrotoxicosis & Thyroid Storm 6.4 Adrenal & Pituitary Disorders: Addisonian Crisis & Pituitary Disease
8 Chapter 7: Neurology & Neurosciences
7.1 Acute Stroke, TIA & Intracranial Haemorrhage 7.2 Acute & Chronic Headaches, Giant Cell Arteritis & CNS Infections 7.3 Seizures, Status Epilepticus & Epilepsy Management 7.4 Neuromuscular Disorders & Movement Disorders 7.5 Raised Intracranial Pressure, Brain Tumours, Cranial Nerve Lesions & Spinal Cord Disorders
9 Chapter 8: Psychiatry & Mental Health
8.1 Affective Disorders: Depression, Bipolar Disorder & Suicide Risk Assessment 8.2 Psychosis, Schizophrenia & Acute Agitation 8.3 Cognitive Disorders, Substance Misuse & the Mental Health Act 8.4 Anxiety Disorders, OCD, PTSD, Eating Disorders, Personality Disorders & Somatic Presentations 8.5 Perinatal, Child & Adolescent and Neurodevelopmental Mental Health
10 Chapter 9: Obstetrics, Gynaecology & Sexual Health
9.1 Early Pregnancy: Miscarriage & Ectopic Pregnancy 9.2 Antenatal & Peripartum Emergencies: Pre-Eclampsia & Haemorrhage 9.3 Common Gynaecological Presentations & Gynaecological Oncology 9.4 Contraception, Emergency Contraception & Sexually Transmitted Infections 9.5 Routine Antenatal Care, Labour & Obstetric Emergencies 9.6 Menopause & HRT, Subfertility, Prolapse & Urinary Incontinence
11 Chapter 10: Paediatrics & Child Health
10.1 The Febrile Child, Sepsis & Meningococcal Disease 10.2 Paediatric Respiratory Distress: Croup, Bronchiolitis & Wheeze 10.3 Paediatric Abdominal Emergencies, Dehydration & Neonatal Jaundice 10.4 Child Safeguarding, Non-Accidental Injury & Developmental Milestones 10.5 Neonatology & Congenital Heart Disease 10.6 Paediatric Orthopaedics, Growth, Childhood Cancer & Common Chronic Problems
12 Chapter 11: Musculoskeletal Medicine & Rheumatology
11.1 Inflammatory Arthropathies & Connective Tissue Diseases 11.2 Crystal Arthropathies (Gout & Pseudogout) & Septic Arthritis 11.3 Osteoporosis, Common Fractures & Orthopaedic Emergencies 11.4 Osteoarthritis, Low Back Pain, Polymyalgia Rheumatica, Fibromyalgia & Soft Tissue Disorders
13 Chapter 12: Dermatology, ENT & Ophthalmology
12.1 Common Dermatoses & Dermatological Emergencies 12.2 ENT Presentations: Infections, Epistaxis, Vertigo, Hearing Loss & Head and Neck Lumps 12.3 The Acute Red Eye: Glaucoma, Uveitis & Keratitis 12.4 Sudden & Gradual Vision Loss, Retinal Disorders & the Visual Pathway 12.5 Skin Infections, Infestations, Childhood Rashes & Skin Cancer
14 Chapter 13: Haematology, Oncology & Palliative Care
13.1 Anaemias & Blood Transfusion Medicine 13.2 Haematological Malignancies: Leukaemias, Lymphomas & Myeloma 13.3 Haemostasis, Coagulation Disorders & Anticoagulant Reversal 13.4 Oncological Emergencies & Palliative Symptom Management 13.5 Breast Disease, Cancer Screening & Suspected Cancer Referral
15 Chapter 14: Perioperative Care, Safe Prescribing & Clinical Pharmacology
14.1 Preoperative Assessment & Perioperative Medication Management 14.2 Postoperative Complications & Fluid Therapy 14.3 High-Risk Medications & Therapeutic Drug Monitoring 14.4 Safe Prescribing Principles & Antimicrobial Stewardship
16 Chapter 15: Medical Ethics, Law & UK Clinical Practice
15.1 GMC Good Medical Practice, Professionalism, Teamwork & Quality Improvement 15.2 Consent, Capacity & the Mental Capacity Act 2005 15.3 Confidentiality, Statutory Reporting & DVLA Regulations 15.4 End-of-Life Decisions, DNACPR, Organ Donation, Adult Safeguarding & Domestic Abuse
17 Chapter 16: Infectious Diseases, Travel Medicine & Infection Prevention
16.1 Tuberculosis, HIV, Hepatitis B & C and Needlestick Injuries 16.2 Fever in the Returning Traveller, Zoonoses, Notifiable Diseases & Infection Prevention
18 Chapter 17: Older Adults, Population Health, Genetics & Clinical Imaging
17.1 Frailty, Falls, Polypharmacy, Continence & Pressure Ulcers 17.2 Medical Statistics, Diagnostic Tests & Critical Appraisal 17.3 Public Health, Screening Principles, Health Inequalities & Health Promotion 17.4 Genetics, Genomics & Pharmacogenomics 17.5 Clinical Imaging: Choosing Tests, Radiation Safety & Interpreting X-rays
14.2 Postoperative Complications & Fluid Therapy
Key Takeaways Explain This Topic AI
The evaluation of postoperative fever is guided by the chronological '5 Ws': Wind (Day 1–2, atelectasis), Water (Day 3, UTI/catheter), Wound (Day 5–7, surgical site infection), Walking (Day 7–10, DVT/PE), and Wonder drugs (any time, drug reactions or malignant hyperthermia).
Acute postoperative oliguria (<0.5 mL/kg/h) requires immediate mechanical catheter flushing to exclude blockage; confirmed pre-renal hypovolaemia is managed with an immediate 500 mL balanced crystalloid fluid challenge over <15 minutes.
Complete abdominal wound dehiscence with evisceration ('burst abdomen') is a surgical emergency: cover exposed bowel loops with sterile saline-soaked swabs, provide IV analgesia, keep nil-by-mouth, and arrange immediate return to theatre.
Malignant hyperthermia is a life-threatening pharmacogenetic emergency (RYR1 mutation) triggered by volatile anaesthetics and suxamethonium; a rapid rise in end-tidal CO2 is the earliest sign, treated immediately by stopping triggers, 100% oxygen hyperventilation, and IV dantrolene (2.5 mg/kg stat).
Last updated: October 2026
Postoperative Complications & Fluid Therapy
Postoperative care requires vigilant clinical monitoring to detect and treat physiological decompensation and surgical complications early. Managing the postoperative surgical patient demands a rigorous, timeline-based diagnostic approach to pyrexia, structured assessment of organ hypoperfusion (notably oliguria), rapid intervention for wound breakdown, and guideline-adherent intravenous fluid prescribing under NICE CG174.
The Timeline Approach to Postoperative Fever: The "5 Ws"
Postoperative pyrexia (temperature ≥38.0°C) is a frequent clinical challenge. Establishing the time elapsed since the operation provides the single most reliable diagnostic discriminator for identifying the underlying etiology.
Postoperative Timeline The "W" Category Primary Etiology & Pathology Clinical Features & UK Management Protocol
Day 1 – 2 Wind Atelectasis (Basal Lung Collapse) ; Less common: Early aspiration pneumonia Shallow breathing secondary to incisional pain, diaphragm splinting, and residual anaesthetic/opioid hypoventilation causes alveolar collapse at the lung bases. Features: Low-grade fever, tachypnoea, mild hypoxia, decreased breath sounds, and fine end-inspiratory crackles at lung bases. Management: Chest physiotherapy, deep breathing exercises, early ambulation, and optimal multi-modal analgesia. Antibiotics are not indicated unless consolidation is confirmed on CXR.
Day 3 Water Urinary Tract Infection (UTI) ; Catheter-Associated UTI (CAUTI) Prolonged indwelling urinary catheterisation, instrumentation, or urinary stasis. Features: Pyrexia, suprapubic tenderness, dysuria, offensive cloudy urine, or new delirium. Management: Send mid-stream urine (MSU) or catheter sample of urine (CSU) for microscopy, culture, and sensitivities. Remove or change the urinary catheter promptly. Initiate narrow-spectrum oral/IV antibiotics according to local trust antimicrobial formulary.
Day 5 – 7 Wound Surgical Site Infection (SSI) ; Superficial or Deep Fascial Microbial contamination of surgical incision (commonest pathogens: Staphylococcus aureus , Streptococcus pyogenes , coliforms, anaerobes). Features: Spreading peri-incisional erythema, localized heat, edema, induration, purulent wound exudate, and exquisite incisional pain. Management: Remove skin clips/sutures to facilitate drainage; send wound swab for culture; prescribe targeted empirical antibiotics; apply sterile non-adherent dressings. If deep collections exist, arrange urgent ultrasound/CT imaging and surgical review.
Day 7 – 10 Walking Venous Thromboembolism (VTE) ; Deep Vein Thrombosis (DVT) & Pulmonary Embolism (PE) Virchow's triad: venous stasis from prolonged immobility, endothelial vessel injury from surgery, and hypercoagulability of tissue trauma. Features: Unilateral lower limb swelling, calf erythema/tenderness; or sudden-onset pleuritic chest pain, dyspnoea, tachypnoea, tachycardia, and haemoptysis. Management: Wells score; lower limb compression Doppler ultrasound; urgent CT Pulmonary Angiogram (CTPA); initiate therapeutic anticoagulation (therapeutic LMWH or DOAC) immediately if suspicion is high, unless actively bleeding.
Any Time Wonder Drugs Drug Fevers & Pharmacological Emergencies Adverse drug reactions, blood transfusion reactions, line infections, or malignant hyperthermia. Culprits: Beta-lactam antibiotics, vancomycin, heparin, sulphonamides, blood products. Management: Systematic medication chart review; cease suspected offending agents; blood cultures from peripheral sites and central venous lines; monitor for systemic signs of drug-induced hypersensitivity or anaphylaxis.
Surgical Wound Complications & Abdominal Evisceration
Surgical wounds heal via complex overlapping phases (haemostasis, inflammation, proliferation, remodelling). Wound complications range from minor superficial infections to catastrophic mechanical disruptions.
Classification of Surgical Site Infections (SSIs)
Superficial Incisional SSI: Involves only skin and subcutaneous tissue of the incision; diagnosed within 30 days of surgery. Characterised by localized erythema, tenderness, and purulent discharge without fascial involvement.
Deep Incisional SSI: Involves deep soft tissues (fascia and muscle layers) of the incision. Manifests with systemic pyrexia, fluctuance, deep fascial breakdown, and purulent drainage from the deep layers.
Organ/Space SSI: Involves any anatomical space deeper than the fascial layers opened or manipulated during surgery (e.g., intra-abdominal abscess, anastomotic leak peritonitis, pelvic collection, subphrenic abscess). Requires urgent contrast-enhanced CT scanning, IV broad-spectrum antimicrobials, and percutaneous or open surgical drainage.
Wound Dehiscence & Burst Abdomen (Evisceration)
Wound dehiscence represents the mechanical separation of previously approximated surgical incision edges. Risk factors include systemic factors (malnutrition, hypoalbuminaemia, active smoking, obesity, chronic corticosteroid therapy, advanced malignancy) and mechanical local factors (wound infection, excessive intra-abdominal pressure from coughing, vomiting, urinary retention, poor suture technique).
Caution
Burst Abdomen Protocol (Surgical Emergency): Complete full-thickness wound dehiscence with evisceration involves failure of all abdominal wall layers, with protrusion of omentum or viable small/large bowel loops onto the skin surface, typically triggered by a sudden cough or strain on postoperative Days 5 to 8 .
Immediate Resuscitation & Stabilization Pathway:
Calm and Position the Patient: Keep the patient in bed in a low-Fowler position (supine with knees gently flexed) to relax abdominal wall musculature and relieve tension on the open wound.
Sterile Cover: Immediately cover the protruding viscera with sterile gauze or towels soaked in warm 0.9% sterile saline . Never allow bowel loops to dry out, and NEVER attempt to push bowel loops back into the peritoneal cavity at the bedside (risks bowel perforation, ischaemia, and gross peritoneal contamination).
Nil-by-Mouth & IV Access: Ensure strict nil-by-mouth; establish large-bore IV access; commence IV balanced crystalloids; administer broad-spectrum IV antimicrobials.
Analgesia: Administer IV opioid analgesia to alleviate pain and distress.
Emergency Return to Operating Theatre: Contact the operating surgical team and theatre coordinator immediately for urgent surgical wound exploration, thorough peritoneal lavage, and formal abdominal wall resuture (often using heavy non-absorbable tension retention sutures, e.g. mass closure with polybutester or nylon, or temporary open abdomen vacuum-assisted closure).
Postoperative Oliguria: Systematic Approach
Acute postoperative oliguria is defined as a urinary output <0.5 mL/kg/h for more than 2 consecutive hours in an adult. In surgical patients, it must be evaluated systematically to differentiate between mechanical obstruction, intravascular hypovolaemia, and established renal parenchymal injury. [ Postoperative Oliguria: <0.5 mL/kg/h ]
- │
- Step 1: Check Catheter Patency
- │
- ┌─────────────────────────────┴─────────────────────────────┐
- ▼ ▼
- [ Catheter Blocked / Kinked ] [ Catheter Patent ]
- Flush with 20-50 mL sterile saline Assess Volume Status: CRT, JVP, BP, HR
- Urine drains freely -> Solved │
- ┌─────────────────────────────┴─────────────────────────────┐
- ▼ ▼
- [ Hypovolaemic / Pre-Renal ] [ Euvolaemic / Hypervolaemic ]
- Tachycardia, low BP, dry mucosae Elevated JVP, lung crackles, edema
- │ │
- Fluid Challenge: Hold fluids; check U&Es;
- 500 mL balanced crystalloid <15 min Evaluate for Acute Tubular Necrosis (ATN)
- Reassess urine output & hemodynamics Consider nephrotoxic drug withdrawal
- Stepwise Management of Postoperative Oliguria
Step 1: Mechanical Catheter Patency Check (Rule Out Post-Renal):
Examine the entire length of the urinary catheter tubing for kinks, dependent loops, or disconnection.
Perform a gentle manual flush with 20–50 mL of sterile 0.9% sodium chloride using an aseptic bladder syringe to dislodge intra-luminal blood clots, mucous plugs, or prostatic debris. If fluid cannot be flushed or fails to return, replace the catheter immediately.
Step 2: Hemodynamic & Volume Status Assessment (Pre-Renal Differentiation):
Review the fluid balance chart: intraoperative blood loss, fluid resuscitation, third-space sequestration, stoma/drain output, and insensible losses.
Physical examination: heart rate, blood pressure, capillary refill time (CRT), postural hypotension, jugular venous pressure (JVP), and mucosal hydration.
Pre-Renal Hypovolaemia (#1 Cause): If hypovolaemia is identified, immediately administer a fluid challenge of 500 mL balanced crystalloid (e.g. Hartmann's solution or Plasma-Lyte) over <15 minutes .
Re-evaluate the clinical response: an increase in blood pressure, deceleration of heart rate, and restoration of urine output to >0.5 mL/kg/h confirms pre-renal hypovolaemia.
Step 3: Renal Parenchymal Injury (Intrinsic Renal Cause):
If oliguria persists despite adequate intravascular volume restoration, suspect Acute Tubular Necrosis (ATN) secondary to prolonged renal hypoperfusion or nephrotoxic insults (e.g., aminoglycosides, NSAIDs, ACE inhibitors, IV iodinated radiocontrast).
Stop all nephrotoxic drugs, monitor electrolytes (hyperkalaemia, metabolic acidosis), review baseline serum creatinine, avoid fluid overloading the anuric patient, and seek urgent nephrology or intensive care guidance.
Postoperative Paralytic Ileus
Postoperative paralytic ileus is a temporary, functional arrest of gastrointestinal peristalsis occurring in the absence of mechanical luminal obstruction. It is an anticipated physiological response following abdominal surgery, typically resolving within 3 to 5 days.
Pathophysiology: Caused by surgical handling and mechanical manipulation of bowel loops, local peritoneal inflammation, sympathetic hyperactivation, electrolyte disturbances (particularly hypokalaemia and hypomagnesaemia ), and systemic opioid analgesia.
Clinical Presentation: Persistent nausea, copious bilious vomiting, progressive painless abdominal distension, failure to pass flatus or stool, and absent or sparse hypoactive bowel sounds on auscultation (in contrast to the high-pitched, tinkling, hyperactive 'borborygmi' of mechanical small bowel obstruction).
Diagnostic Distinction: Plain abdominal radiographs or CT scanning reveal diffuse, uniform gaseous distension involving both small and large bowel loops with air in the rectum, without an identifiable discrete mechanical transition point.
Management: The "Drip and Suck" Protocol:
Drip: Intravenous crystalloid fluid replacement tailored to replace nasogastric and third-space losses, with diligent correction of hypokalaemia (maintain K+ >4.0 mmol/L) and hypomagnesaemia.
Suck: Insertion of a wide-bore nasogastric (NG) tube on free drainage with regular 4-hourly aspiration to decompress the stomach, relieve vomiting, and prevent pulmonary aspiration.
Conservative Measures: Keep nil-by-mouth; mobilize the patient; discontinue or minimize opioid analgesics (switch to paracetamol, regional epidural/transversus abdominis plane blocks, or low-dose adjuncts); encourage chewing gum (sham feeding stimulates cephalic-vagal gastrointestinal motility).
Malignant Hyperthermia: Pharmacogenetic Emergency
Malignant Hyperthermia (MH) is a rare, life-threatening pharmacogenetic disorder of skeletal muscle calcium homeostasis inherited in an autosomal dominant pattern with variable penetrance. In >70% of cases, it results from gain-of-function mutations in the ryanodine receptor gene ( RYR1 ) on chromosome 19, which encodes the principal calcium release channel of the sarcoplasmic reticulum.
Pharmacological Triggers: Triggered by exposure to:
Volatile Inhalational Anaesthetic Agents: Sevoflurane, isoflurane, desflurane, halothane.
Depolarising Neuromuscular Blocking Drugs: Suxamethonium (succinylcholine).
Pathogenesis: Uncontrolled, massive efflux of intracellular calcium from the sarcoplasmic reticulum into the myoplasm overrides normal sarcoplasmic reticular reuptake mechanisms, producing sustained, intense skeletal muscle contraction, catastrophic aerobic and anaerobic hypermetabolism, rapid depletion of ATP, excessive heat generation, severe lactic acidosis, and massive rhabdomyolysis.
Clinical Features & Timeline:
Earliest & Most Sensitive Sign: Unexplained, rapidly rising end-tidal CO₂ (hypercapnia) that is refractory to massive increases in mechanical minute ventilation.
Early Signs: Unexplained sinus tachycardia, tachypnoea, labile blood pressure, and masseter muscle spasm (jaw rigidity) following suxamethonium administration.
Hypermetabolic Progression: Severe mixed respiratory and high-anion-gap metabolic (lactic) acidosis, hyperkalaemia, generalized board-like muscle rigidity, cyanosis, skin mottling, and cardiac arrhythmias.
Rhabdomyolysis: Massive elevation in serum creatine kinase (CK >20,000 U/L), myoglobinuria (dark red-brown 'tea-coloured' urine), and acute renal failure.
Hyperthermia (Late Sign): A dramatic, exponential rise in core body temperature (rising by 1–2°C every 5 minutes, frequently exceeding 41–42°C); hyperthermia is a late, confirmatory manifestation of advanced hypermetabolism.
Warning
Emergency Management Protocol for Malignant Hyperthermia:
Cease Triggering Agents Immediately: Turn off volatile anaesthetic vaporizers immediately; stop suxamethonium; conclude or abort surgery as rapidly as possible.
Hyperventilate with 100% Oxygen: Deliver 100% oxygen at maximum fresh gas flows (≥10 L/min) using a clean circuit or charcoal filters to wash out residual volatile agents.
Administer IV Dantrolene Sodium: Give Dantrolene 2.5 mg/kg IV stat as a rapid intravenous bolus. Dantrolene is a specific ryanodine receptor antagonist that binds the RYR1 channel, directly halting calcium release from the sarcoplasmic reticulum. Repeat boluses of 1 mg/kg every 5–10 minutes until hypermetabolism, muscle rigidity, tachycardia, and hypercapnia resolve (cumulative dose up to 10 mg/kg ).
Active Core Cooling: Infuse cold intravenous 0.9% saline (4°C); apply surface ice packs to the axillae, groin, and neck; perform cold gastric lavage. Cease active cooling once core temperature drops below 38.5°C to prevent hypothermic overshoot.
Treat Severe Hyperkalaemia: Administer IV 10% calcium chloride (10 mL) or calcium gluconate to stabilize the cardiac membrane, followed by an IV infusion of 50 mL 50% glucose with 10 units soluble insulin (Actrapid) and IV sodium bicarbonate for severe acidosis.
Renal Protection: Maintain high urinary flow (>2 mL/kg/h) via vigorous IV hydration and IV furosemide or mannitol to prevent myoglobin precipitation in renal tubules and acute tubular necrosis.
Intravenous Fluid Therapy in Adults (NICE CG174 Guidelines)
Prescribing intravenous fluids in surgical inpatients must be treated with the same pharmacological precision as any therapeutic drug. Over-prescription of 0.9% normal saline induces hyperchloraemic metabolic acidosis and tissue edema; under-prescription triggers prerenal hypovolaemia and AKI.
The 4 "Rs" of Fluid Management
Resuscitation: Urgent restoration of circulating intravascular volume in patients with shock or severe hypoperfusion.
Routine Maintenance: Daily baseline requirements for stable patients unable to meet needs enterally.
Replacement: Offsetting ongoing abnormal fluid and electrolyte losses (vomiting, diarrhea, stoma, fistulae, surgical drains, polyuria).
Redistribution: Compensating for third-space fluid shifts, gross edema, or hypoalbuminaemia.
Fluid Resuscitation Protocol
If a patient exhibits clinical signs of shock (systolic BP <90 mmHg, HR >100 bpm, CRT >2 seconds, respiratory rate >20, oliguria):
Immediately administer a 500 mL bolus of crystalloid containing sodium in the range 130–154 mmol/L (e.g., Hartmann's solution, Plasma-Lyte, or 0.9% sodium chloride) over less than 15 minutes .
Reassess following the ABCDE approach. If the patient remains hypoperfused, repeat 250–500 mL boluses up to a cumulative volume of 2000 mL, seeking senior/intensive care assistance.
Routine Maintenance Requirements (Per 24 Hours)
For an adult who is clinically euvolaemic and has no ongoing abnormal fluid losses:
- Maintenance Component Daily Requirement (NICE CG174) Typical 24-Hour Requirement for 70 kg Adult
- Water 25 – 30 mL/kg/day 1750 – 2100 mL/day (~2.0 L/day)
- Sodium (Na⁺) 1 mmol/kg/day ~70 mmol/day
- Potassium (K⁺) 1 mmol/kg/day ~70 mmol/day
- Chloride (Cl⁻) 1 mmol/kg/day ~70 mmol/day
- Glucose 50 – 100 g/day 50 – 100 g/day (prevents starvation ketosis)
Tip
Daily Maintenance Prescription for a 70 kg Adult (NICE CG174): NICE suggests a hypotonic maintenance fluid providing roughly 25–30 mL/kg/day of water, about 1 mmol/kg/day each of sodium, potassium and chloride, and 50–100 g glucose; for example, 2 L of 0.18% sodium chloride with 4% glucose and 20–27 mmol potassium chloride per litre over 24 hours . A regimen of 1 L 0.9% sodium chloride plus 1 L 5% glucose gives 154 mmol of sodium, about twice the daily requirement, so it suits patients with ongoing sodium losses rather than routine maintenance. Weigh, check electrolytes and reassess daily, and reduce volumes in older, frail, cardiac or renal patients; hypotonic fluids carry a risk of hyponatraemia, so monitor sodium closely.